Nodapton en es it fr

Nodapton Brand names, Nodapton Analogs

Nodapton Brand Names Mixture

  • No information avaliable

Nodapton Chemical_Formula


Nodapton RX_link

Nodapton fda sheet

Nodapton FDA

Nodapton msds (material safety sheet)

Nodapton MSDS

Nodapton Synthesis Reference

No information avaliable

Nodapton Molecular Weight

318.431 g/mol

Nodapton Melting Point

192.5 oC

Nodapton H2O Solubility

No information avaliable

Nodapton State


Nodapton LogP


Nodapton Dosage Forms

Liquid; Tablet

Nodapton Indication

For use as a preoperative antimuscarinic to reduce salivary, tracheobronchial, and pharyngeal secretions, to reduce the volume and free acidity of gastric secretions and to block cardiac vagal inhibitory reflexes during induction of anesthesia and intubation.

Nodapton Pharmacology

Glycopyrrolate decreases acid secretion in the stomach. Hence it can be used for treating ulcers in the stomach and small intestine, in combination with other medications. In anesthesia, glycopyrrolate injection serves as a preoperative antimuscarinic operation that reduces salivary, tracheobronchial, and pharyngeal secretions, as well as decreases the acidity of gastric secretions blocks cardiac vagal inhibitory reflexes during intubation

Nodapton Absorption

Rapidly absorbed (1-2 minutes) after intravenous injection

Nodapton side effects and Toxicity

Side effects include dry mouth, difficult urinating, heachaches, diarrhea and constipation. The medication also induces drowsiness or blurred vision. LD50=709 mg/kg (rat, oral).

Nodapton Patient Information

No information avaliable

Nodapton Organisms Affected

Humans and other mammals